Abstract:Aging represents the most important risk factor for many chronic diseases including cardiovascular diseases, diabetes, and cancer, therefore understanding the mechanisms of aging is a fundamental step for designing new treatments for chronic diseases. DNA methylation is the most reliable and accurate molecular marker for aging quantification, however, genome‐wide DNA methylation profiling techniques, such as reduced representative bisulfite sequencing and Illumina Bead Array that are widely used in aging research are prohibitively expensive and have poor data quality at low‐read coverage sites. Here we report a robust targeted bisulfite sequencing approach, called SWARM™ (Simplified Whole‐panel Amplification Reaction Method), for the accurate biological age determination. SWARM™ is flexible and low cost, requires relatively low DNA input, allows the simultaneous amplification and sequencing of hundreds of loci, and has shown to increase sample throughput. Using the SWARM™ approach, we were able to analyze the methylation level of several hundreds of age‐associated loci including the published Horvath Clock sites. An age‐predictive model was built using the elastic net regression of DNA methylation levels of the loci and chronological age of blood DNA samples of over 300 healthy subjects of 18 to 89 years old. Our epigenetic age (DNAge™) predictor achieved a small median age error, and the DNAge™ of samples that were processed on both sequencing and array platforms highly correlated (r > 0.9). In brief, our versatile SWARM™ technology‐based DNAge™ platform is a very fast and accurate tool for the precise biological aging quantification and aging interventions monitoring. Dedicated DNAge™ platforms are compatible with various sample types, and can be applied for aging studies in human, and in other species including mice.This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.

Systems Age: A single blood methylation test to quantify aging heterogeneity across 11 physiological systems

Blood Omics Models for System-Specific Mortality Risk Estimation

Models for Evaluation of Biological Age Based on Multi-omics

Distinct biological ages of organs and systems identified from a multi-omics study

Underlying features of epigenetic aging clocks in vivo and in vitro

ComputAgeBench: Epigenetic Aging Clocks Benchmark

An epigenetic biomarker of aging for lifespan and healthspan

A hematology-based clock derived from the Study of Longitudinal Aging in Mice to estimate biological age

A High‐throughput Targeted Bisulfite Sequencing‐based Analysis for Epigenetic Age Quantification and Monitoring

A computational solution for bolstering reliability of epigenetic clocks: Implications for clinical trials and longitudinal tracking

A molecular index for biological age identified from the metabolome and senescence‐associated secretome in humans

A systematic review of phenotypic and epigenetic clocks used for aging and mortality quantification in humans

scEpiAge: an age predictor highlighting single-cell ageing heterogeneity in mouse blood

High-dimensional Ageome Representations of Biological Aging across Functional Modules

Epigenetic Clock for Skin and Blood Cells Applied to Hutchinson Gilford Progeria Syndrome and Ex Vivo Studies.

Epigenetic and Metabolomic Biomarkers for Biological Age: A Comparative Analysis of Mortality and Frailty Risk

Quantification of Epigenetic Aging in Public Health

Socioeconomic position, lifestyle habits and biomarkers of epigenetic aging: a multi-cohort analysis

Cross-Tissue Comparison of Epigenetic Aging Clocks in Humans

Cell-type specific epigenetic clocks to quantify biological age at cell-type resolution

Chronological Age Prediction: Developmental Evaluation of DNA Methylation-Based Machine Learning Models